Cerebrospinal Fluid Shunts
Hydrocephalus
Cerebrospinal Fluid
MedlinePlus
Hydrocephalus, Normal Pressure
Water
Ventriculoperitoneal Shunt
Treatment of hydrocephalus secondary to cryptococcal meningitis by use of shunting. (1/310)
Hydrocephalus can be associated with increased morbidity and mortality in cryptococcal meningitis if left untreated. Both ventriculoperitoneal and ventriculoatrial shunting have been used in persons with cryptococcosis complicated by hydrocephalus, but the indications for and complications, success, and timing of these interventions are not well known. To this end, we reviewed the clinical courses of 10 non-human immunodeficiency virus-infected patients with hydrocephalus secondary to cryptococcal meningitis who underwent shunting procedures. Nine of 10 patients who underwent shunting had noticeable improvement in dementia and gait. Two patients required late revision of their shunts. Shunt placement in eight patients with acute infection did not disseminate cryptococcal infection into the peritoneum or bloodstream, nor did shunting provide a nidus from which Cryptococcus organisms proved difficult to eradicate. Shunting procedures are a safe and effective therapy for hydrocephalus in patients with cryptococcal meningitis and need not be delayed until patients are mycologically cured. (+info)Link between the CSF shunt and achievement in adults with spina bifida. (2/310)
OBJECTIVES: A few enterprising adults with shunt treated spina bifida live independently in the community, have a job in competitive employment, and drive to work in their own car. By contrast others with similar disability but lacking their motivation remain dependent on care and supervision. The aim of this study was to identify events in the history of their shunt which may have influenced their subsequent achievement. METHODS: Between June 1963 and January 1971 117 babies born in East Anglia with open spina bifida had their backs closed regardless of the severity of their condition. When reviewed in 1997 every case was ascertained. Sixty had died and the 57 survivors had a mean age of 30. These were assigned to two groups: achievers and non-achievers, according to their attainments in independence, employment, and use of a car. RESULTS: Of the 57 survivors nine had no shunt and eight of these were achievers. All were of normal intelligence (IQ>/=80) and only one was severely disabled. Of the 48 with shunts only 20 were achievers (OR 11.2, 95% confidence interval (95% CI) 1.3-96.8). Lack of achievement in these 48 was associated with revisions of the shunt, particularly when revisions were performed after the age of 2. Sixteen patients had never required a revision and 11 (69%) were achievers; 10 had had revisions only during infancy and five (50%) were achievers; 22 had had revisions after their second birthday and only four (18%) were achievers (p<0.001). Elective revisions were not performed in this cohort and in 75% of patients revisions had been preceded by clear symptoms of raised intracranial pressure. CONCLUSION: Revisions of the shunt, particularly after the age of 2, are associated with poor long term achievement in adults with spina bifida. (+info)Effect of cerebrospinal fluid shunting on experimental syringomyelia: magnetic resonance imaging and histological findings. (3/310)
The histological changes associated with syringomyelia after reduction of the syrinx size were investigated after cerebrospinal fluid shunting in experimental syringomyelia in the rabbit. Five weeks after syringomyelia was induced by the injection of kaolin into the cisterna magna in Japanese white rabbits, ventriculosubgaleal shunting or syringoepidural shunting were performed. After 1 week magnetic resonance (MR) imaging and histological examination were then carried out. Five of 11 shunted animals showed postoperative reduction of syrinx size on MR imaging. Grossly, some specimens showed cavity collapse and parenchymal healing, and others showed a small residual syrinx in the dorsal horn. The most dramatic histological changes occurred in the gray matter. Specimens with syrinx collapse showed rarefaction and tearing of the gray matter, with mild glial reaction. The edematous gray matter showed both degeneration and regeneration, with neuronal processes surrounded by edema fluid. Reactive astrocytes were observed mainly at the margin of the residual syrinx. Some astrocytic processes invested the extraaxonal space and gray matter lacked supportive tissue. Greater reduction of the syrinx after shunting operation was correlated with more regeneration and less degeneration, and the white matter was edematous and histological changes were milder. Syrinx shrinkage occurred after shunting in this experimental model of syringomyelia. The selective vulnerability of gray matter even after shunting may explain discrepancies between imaging findings and clinical features in this disease. The study supports the potential benefit from early treatment, considering the associated morphological findings of regeneration. (+info)Specific patterns of cognitive impairment in patients with idiopathic normal pressure hydrocephalus and Alzheimer's disease: a pilot study. (4/310)
OBJECTIVES: Eleven patients with idiopathic normal pressure hydrocephalus (NPH) were selected from an initial cohort of 43 patients. The patients with NPH fell into two distinctive subgroups: preshunt, group 1 (n=5) scored less than 24 on the mini mental state examination (MMSE) and were classified as demented and group 2 (n=6) scored 24 or above on the MMSE and were classified as non-demented. METHODS: All patients were neuropsychologically assessed on two occasions: preshunt and then again 6 months postshunt. Group 1 completed the mini mental state examination (MMSE) and the Kendrick object learning test (KOLT). In addition to the MMSE and KOLT, group 2 completed further tasks including verbal fluency and memory and attentional tasks from the CANTAB battery. Nine of the 11 patients also underwent postshunt MRI. RESULTS: Group 1, who, preshunt, performed in the dementing range on both the MMSE and KOLT, showed a significant postoperative recovery, with all patients now scoring within the normal non-demented range. Group 2, although showing no signs of dementia according to the MMSE and KOLT either preshunt or postshunt, did show a specific pattern of impairment on tests sensitive to frontostriatal dysfunction compared with healthy volunteers, and this pattern remained postoperatively. Importantly, this pattern is distinct from that exhibited by patients with mild Alzheimer's disease. Eight of the nine patterns of structural damage corresponded well to cognitive performance. CONCLUSIONS: These findings are useful for three main reasons: (1) they detail the structural and functional profile of impairment seen in NPH, (2) they demonstrate the heterogeneity found in this population and show how severity of initial cognitive impairment can affect outcome postshunt, and (3) they may inform and provide a means of monitoring the cognitive outcome of new procedures in shunt surgery. (+info)Dandy-Walker syndrome successfully treated with cystoperitoneal shunting--case report. (5/310)
A neonate presented with Dandy-Walker syndrome manifesting as a large posterior cranial fossa cyst, aplasia of the lower cerebellar vermis, and elevation of the confluence of the sinuses but without hydrocephalus. A cystoperitoneal shunt was placed at one month after birth. The cyst diminished in size, and marked development of the cerebellar hemispheres and descent of the confluence of sinuses were observed, but not vermis development. The primary pathology of Dandy-Walker syndrome is posterior cranial fossa cyst formation due to passage obstruction in the fourth ventricle exit area and aplasia of the lower cerebellar vermis. The first choice of treatment in patients with Dandy-Walker syndrome in whom the cerebral aqueduct is open is cystoperitoneal shunt surgery, regardless of the presence or absence of hydrocephalus. (+info)Prediction of effectiveness of shunting in patients with normal pressure hydrocephalus by cerebral blood flow measurement and computed tomography cisternography. (6/310)
Measurement of cerebral blood flow (CBF) and computed tomography (CT) cisternography were performed in 37 patients with a tentative diagnosis of normal pressure hydrocephalus (NPH) to predict their surgical outcome. The mean CBF of the whole brain was measured quantitatively by single photon emission computed tomography with technetium-99m-hexamethylpropylene amine oxime before surgery. The results of CT cisternography were classified into four patterns: type I, no ventricular stasis at 24 hours; type II, no ventricular stasis with delayed clearance of cerebral blush; type III, persistent ventricular stasis with prominent cerebral blush; type IV, persistent ventricular stasis with diminished cerebral blush and/or asymmetrical filling of the sylvian fissures. The mean CBF was significantly lower than that of age-matched controls (p < 0.005). Patients with a favorable outcome had a significantly higher mean CBF than patients with an unfavorable outcome (p < 0.005). Patients with the type I pattern did not respond to shunting. Some patients with type II and III patterns responded to shunting but improvement was unsatisfactory. Patients with type IV pattern responded well to shunting, and those with a mean CBF of 35 ml/100 g/min or over achieved a favorable outcome. The combination of CBF measurement and CT cisternography can improve the prediction of surgical outcome in patients with suspected NPH. (+info)MR imaging of the hippocampus in normal pressure hydrocephalus: correlations with cortical Alzheimer's disease confirmed by pathologic analysis. (7/310)
BACKGROUND AND PURPOSE: MR studies have shown hippocampal atrophy to be a sensitive diagnostic feature of Alzheimer's disease (AD). In this study, we measured the hippocampal volumes of patients with a clinical diagnosis of normal pressure hydrocephalus (NPH), a potentially reversible cause of dementia when shunted. Further, we examined the relationship between the hippocampal volumes and cortical AD pathologic findings, intracranial pressure, and clinical outcomes in cases of NPH. METHODS: We measured hippocampal volumes from 37 patients with a clinical diagnosis of NPH (27 control volunteers and 24 patients with AD). The patients with NPH underwent biopsy, and their clinical outcomes were followed for a year. RESULTS: Compared with those for control volunteers, the findings for patients with NPH included a minor left-side decrease in the hippocampal volumes (P < .05). Compared with those for patients with AD, the findings for patients with NPH included significantly larger hippocampi on both sides. Although not statistically significant, trends toward larger volumes were observed in patients with NPH who had elevated intracranial pressure, who benefited from shunting, and who did not display cortical AD pathologic findings. CONCLUSIONS: Measurements of hippocampal volumes among patients with a clinical diagnosis of NPH have clear clinical implications, providing diagnostic discrimination from AD and possibly prediction of clinical outcome after shunting. (+info)Indications for shunting in patients with idiopathic normal pressure hydrocephalus presenting with dementia and brain atrophy (atypical idiopathic normal pressure hydrocephalus). (8/310)
The indications for shunt operation in patients with idiopathic normal pressure hydrocephalus accompanied by brain atrophy (atypical idiopathic normal pressure hydrocephalus: AINPH) were investigated in 25 patients who satisfied the diagnostic criteria and underwent ventriculoperitoneal (VP) shunting. All patients had no apparent history of intra- or extracranial disease; dementia and gait disturbance as the main complaints; moderate to severe cerebral atrophy and ventricular dilatation and at least periventricular low density around the anterior horn on computed tomography; normal cerebrospinal fluid (CSF) pressure and filling of ventricles or cortical surface space with contrast medium at 24 hours on cisternography. The 15 male and 10 female patients were aged 47-83 years (mean 60.4 years). VP shunting was effective in 12 improved patients and not effective in 13 unimproved patients according to NPH grading. Pathological pressure wave on epidural pressure monitoring was observed in eight of 12 improved patients, but none of 13 unimproved patients. CSF outflow resistance was 35.33 +/- 11.16 mmHg/ml/min in improved patients and 9.12 +/- 3.51 mmHg/ml/min in unimproved patients. Preoperative serum alpha-1-antichymotrypsin value (alpha-1-ACT) was 42.02 +/- 8.64 mg/dl in improved patients and 61.72 +/- 11.03 mg/dl in unimproved patients. Alpha-1-ACT over 55 mg/dl occurred only in unimproved patients. Cerebral arteriovenous difference of oxygen content value (c-AVDO2) before and after surgery was 6.34 +/- 0.9 ml% and 5.91 +/- 0.78 ml% in improved patients and 4.75 +/- 1.85 ml% and 4.81 +/- 1.73 ml% in unimproved patients, respectively. The two cases with preoperative c-AVDO2 value over 8.5 ml% were both unimproved. Mean cerebral blood flow value before and after surgery was 23.51 +/- 4.20 ml/100 g/min and 45.22 +/- 8.11 ml/100 g/min in improved patients and 21.77 +/- 5.12 ml/100 g/min and 24.82 +/- 4.97 ml/100 g/min in unimproved patients, respectively. Cerebral atrophy in improved patients is caused by a cerebral circulation disturbance defined as a cerebral blood flow of penumbra or more due to cerebral arteriosclerosis, etc. A flow-chart of indications of shunt surgery for AINPH was prepared based on the results of the present study. (+info)There are several types of hydrocephalus, including:
1. Aqueductal stenosis: This occurs when the aqueduct that connects the third and fourth ventricles becomes narrowed or blocked, leading to an accumulation of CSF in the brain.
2. Choroid plexus papilloma: This is a benign tumor that grows on the surface of the choroid plexus, which is a layer of tissue that produces CSF.
3. Hydrocephalus ex vacuo: This occurs when there is a decrease in the volume of brain tissue due to injury or disease, leading to an accumulation of CSF.
4. Normal pressure hydrocephalus (NPH): This is a type of hydrocephalus that occurs in adults and is characterized by an enlarged ventricle, gait disturbances, and cognitive decline, despite normal pressure levels.
5. Symptomatic hydrocephalus: This type of hydrocephalus is caused by other conditions such as brain tumors, cysts, or injuries.
Symptoms of hydrocephalus can include headache, nausea, vomiting, seizures, and difficulty walking or speaking. Treatment options for hydrocephalus depend on the underlying cause and may include medication, surgery, or a shunt to drain excess CSF. In some cases, hydrocephalus can be managed with lifestyle modifications such as regular exercise and a balanced diet.
Prognosis for hydrocephalus varies depending on the underlying cause and severity of the condition. However, with timely diagnosis and appropriate treatment, many people with hydrocephalus can lead active and fulfilling lives.
Symptoms of hydrocephalus, normal pressure can include headaches, nausea and vomiting, double vision, and difficulty with balance and coordination. However, unlike hydrocephalus, elevated pressure, which is caused by an excessive accumulation of CSF, the symptoms of hydrocephalus, normal pressure are usually milder and may not be as severe.
Treatment options for hydrocephalus, normal pressure can include medications to relieve symptoms, such as headaches and nausea, as well as surgery to drain excess CSF or to repair any blockages or abnormalities in the flow of CSF. In some cases, a shunt may be inserted to drain excess CSF into another part of the body, such as the abdomen.
Cerebral shunt
Huntington Medical Research Institutes
Eldon Leroy Foltz
Neurosurgery
Encephalocele
Endoscopic third ventriculostomy
Hydrocephalus
Maroteaux-Lamy syndrome
Pineoblastoma
Idiopathic intracranial hypertension
L1 syndrome
Ventricular system
Anaerobic infection
John Pickard (neurosurgeon)
Dental antibiotic prophylaxis
Siphon
July effect
Staphylococcus haemolyticus
List of MeSH codes (E04)
Visual impairment due to intracranial pressure
Low pressure hydrocephalus
Craniotomy
CSF tap test
Lumbar-peritoneal shunt
Neuroplastic surgery
ShuntCheck
Shunt nephritis
Cerebrospinal fluid diversion
Cerebral venous sinus thrombosis
Syringomyelia
Papillary tumors of the pineal region
Chronic cerebrospinal venous insufficiency controversy
External ventricular drain
Neural tube defect
Outline of the human brain
Porencephaly
Normal pressure hydrocephalus
Interventional radiology
Choroid plexus carcinoma
Bobble-head doll syndrome
Neurohydrodynamics
Lymphocytic choriomeningitis
Keen's point
Cerebrospinal fluid
Cryptococcus gattii
Homeostasis
Peritoneal cavity
Ventriculostomy
James Edward Cottrell
Spina bifida
PA-09-206: Advanced Tools and Technologies for Cerebrospinal Fluid Shunts SBIR (R43/R44)
Continuous, noninvasive wireless monitoring of flow of cerebrospinal fluid through shunts in patients with hydrocephalus. |...
Macrocephaly, increased intracranial pressure, and hydrocephalus in the infant and young child
Table - Community-acquired Methicillin-resistant Staphylococcus aureus, Uruguay - Volume 11, Number 6-June 2005 - Emerging...
Bacterial Meningitis Empiric Therapy: Empiric Therapy Regimens
201405 Use of 3-D Printers for the Production of Medical Devices | NICHD - Eunice Kennedy Shriver National Institute of Child...
Publication Detail
Janet A Englund, MD
Treating Normal Pressure Hydrocephalus (NPH) with a Shunt
Hydrocephalus | Water on the Brain | MedlinePlus
Biomarkers Search
Asian J Neurosurg Volume 18(2); 2023 Jun - PMC
Hydrocephalus and Cerebral Fluid Center | Johns Hopkins Neurology and Neurosurgery
DailyMed - LINEZOLID injection, solution
Papilledema | Harvard Catalyst Profiles | Harvard Catalyst
Cerebral Aneurysms | National Institute of Neurological Disorders and Stroke
VP Shunts: How They Work, Risks, Benefits, and More
Publications
Polymers | Free Full-Text | Plant Secondary Metabolite-Derived Polymers: A Potential Approach to Develop Antimicrobial Films
About MPS VI - HCP
MeSH Browser
Fogarty-supported research revolutionizes hydrocephalus care - Fogarty International Center @ NIH
Cerebrospinal Fluid Management Products Market Updates, News and Data, Market Players - DePuy Synthes, Sophysa S.A.,...
Success! Abigael from Kenya raised $685 to fund brain surgery. | Watsi
Hydrocephalus - Augusta Health
Dexamethasone therapy versus surgery for chronic subdural haematoma (DECSA trial): study protocol for a randomised controlled...
MeSH Browser
DeCS
Hydrocephalus34
- This Funding Opportunity Announcement (FOA) invites Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) for projects to design and develop advanced tools and technologies for cerebrospinal fluid (CSF) shunts that will lead to improved clinical treatment for patients with hydrocephalus. (nih.gov)
- Continuous, noninvasive wireless monitoring of flow of cerebrospinal fluid through shunts in patients with hydrocephalus. (bvsalud.org)
- Hydrocephalus is a common disorder caused by the buildup of cerebrospinal fluid (CSF) in the brain . (bvsalud.org)
- Taken together, the results suggest a significant advance in monitoring capabilities for patients with shunted hydrocephalus , with potential for practical use across a range of settings and circumstances, and additional utility for research purposes in studies of CSF hydrodynamics . (bvsalud.org)
- Shunting improved hydrocephalus symptoms in 95% of the patients and Karnofsky Performance Score (KPS) could be restored after shunting. (frontiersin.org)
- Although glioblastoma treatment remains challenging, shunting improved hydrocephalus-related functional status and may be considered even in a palliative setting for symptom relief. (frontiersin.org)
- 2. [Pregnancy and delivery in women with cerebrospinal fluid shunt due to hydrocephalus]. (nih.gov)
- 3. Hydrocephalus and the reproductive health of women: the medical implications of maternal shunt dependency in 70 women and 138 pregnancies. (nih.gov)
- 10. [Hydrocephalus with cerebrospinal fluid shunts and pregnancy: 2 cases]. (nih.gov)
- 11. [Gestation and spontaneous delivery in hydrocephalus with ventriculoperitoneal shunt]. (nih.gov)
- Implanting shunts usually takes less than an hour, and may help relieve symptoms of normal pressure hydrocephalus. (medtronic.com)
- Shunts have been used to treat hydrocephalus for more than 50 years. (medtronic.com)
- Hydrocephalus is the buildup of too much cerebrospinal fluid in the brain. (medlineplus.gov)
- 2. Prevention of ventricular catheter obstruction and slit ventricle syndrome by the prophylactic use of the Integra antisiphon device in shunt therapy for pediatric hypertensive hydrocephalus: a 25-year follow-up study. (nih.gov)
- 4. CSF shunt removal in children with hydrocephalus. (nih.gov)
- 8. [Evaluation of shunt treatment in hydrocephalus with myelomeningocele: some factors relating to mental prognosis]. (nih.gov)
- 12. [Sonographic position and functional diagnosis of ventricular positioned shunt systems in infants with hydrocephalus]. (nih.gov)
- 13. To shunt or not to shunt: hydrocephalus and dysraphism. (nih.gov)
- 15. Do antibiotic-impregnated shunts in hydrocephalus therapy reduce the risk of infection? (nih.gov)
- 20. Ventricular catheter placement accuracy in non-stereotactic shunt surgery for hydrocephalus. (nih.gov)
- The experts at the Johns Hopkins Hydrocephalus and Cerebral Fluid Center evaluate and treat patients with all forms of disorders affecting cerebral fluid (also called cerebrospinal fluid, CSF or spinal fluid), including conditions related to the accumulation of CSF in the brain (hydrocephalus). (hopkinsmedicine.org)
- The Johns Hopkins Hydrocephalus and Cerebral Fluid Center continues a 100-year legacy of research and treatment for patients diagnosed with hydrocephalus and CSF disorders. (hopkinsmedicine.org)
- Their emplacement permits draining of cerebrospinal fluid for relief of hydrocephalus or other condition leading to fluid accumulation in the ventricles. (nih.gov)
- A buildup of excess cerebrospinal fluid (CSF) is called hydrocephalus . (webmd.com)
- Abigael has been diagnosed with hydrocephalus, a condition in which excess cerebrospinal fluid accumulates in the brain and increases intracranial pressure. (watsi.org)
- Symptoms of hydrocephalus include an enlarged head size, irritability, abnormal accumulation of cerebrospinal fluid in the brain, and increased intracranial pressure. (watsi.org)
- Surgical treatment for hydrocephalus can restore and maintain normal cerebrospinal fluid levels in the brain. (watsi.org)
- Developed by Dr. Benjamin Warf after he noticed "an enormous number of babies with hydrocephalus" presenting at a Ugandan children's neurosurgery clinic, the treatment allows doctors to avoid placing a shunt in babies to drain excess cerebrospinal fluid from the brain. (nih.gov)
- Warf himself placed shunts, the predominant treatment worldwide for hydrocephalus for several decades, in hundreds of babies with hydrocephalus during his first few years in Uganda, but in the back of his mind was the nagging thought that, while he was treating one problem, he was creating another - shunt dependence. (nih.gov)
- So, with a grant through Fogarty's brain disorders program, largely funded by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) , Warf and his colleagues ran a randomized controlled trial to compare outcomes after ETV-CPC and shunting in babies with post-infectious hydrocephalus. (nih.gov)
- Hydrocephalus is the buildup of fluid in the cavities (ventricles) deep within the brain. (augustahealth.com)
- But the pressure of too much cerebrospinal fluid associated with hydrocephalus can damage brain tissues and cause a range of brain function problems. (augustahealth.com)
- Hydrocephalus is caused by an imbalance between how much cerebrospinal fluid is produced and how much is absorbed into the bloodstream. (augustahealth.com)
- A spinal tap may also be done to establish the diagnosis of normal pressure hydrocephalus or bleeding into the spinal fluid from an aneurysm. (nih.gov)
Ventriculoperitoneal5
- Prophylactic sulfamethoxazole and trimethoprim in ventriculoperitoneal shunt surgery. (nih.gov)
- 17. Anesthesia for urgent sequential ventriculoperitoneal shunt revision and cesarean delivery. (nih.gov)
- 18. Safety of Pregnancy in Ventriculoperitoneal Shunt Dependent Women: Meta-analysis and Systematic Review of the Literature. (nih.gov)
- A ventriculoperitoneal (VP) shunt is a narrow plastic tube that drains excess cerebrospinal fluid into your abdomen (belly). (webmd.com)
- A ventriculoperitoneal shunt has a one-way valve, a device that only allows fluid to move down away from the brain. (webmd.com)
Ventricular2
- CSF may also be collected from a tube that is already placed in the fluid, such as a shunt or a ventricular drain. (nih.gov)
- Prissy wears elbow splints to prevent her from reaching and thus yanking on the complex bidirectional ventricular shunt bundle through which excess cerebrospinal fluid drains and through which stem cells and neurogenerators feed into the corpus callosum and surrounding cerebral cortex. (redstonesciencefiction.com)
Placement4
- One primary outcome was a composite of fetal or neonatal death or the need for placement of a cerebrospinal fluid shunt by the age of 12 months. (nih.gov)
- Shunt placement to help drain cerebrospinal fluid and redirect it to another location in the body where it can be reabsorbed. (hopkinsmedicine.org)
- This is important because half of shunts fail within two years of placement and all fail within five to 10 years," said Warf. (nih.gov)
- Scientists knew that ETV-CPC is less likely to fail over the long term but didn't reduce the size of the ventricle as much as shunt placement did, raising concerns that cognitive development would be compromised in children who had the new procedure. (nih.gov)
Drain6
- Shunts allow excess cerebrospinal fluid to drain to another area of the body. (medtronic.com)
- When there is too much cerebrospinal fluid and pressure starts to build, the valve opens and allows CSF to drain until the pressure is restored to the setting chosen by your doctor. (webmd.com)
- The procedure is scheduled to take place on March 28 and will drain the excess fluid from Abigael's brain. (watsi.org)
- Abigael had a successful surgery to drain the excess fluid. (watsi.org)
- One, endoscopic third ventriculostomy (ETV), involves making an opening in one of the ventricles, or cavities, of the brain to allow fluid to drain, and the other, choroid plexus cauterization (CPC), reduces the amount of cerebrospinal fluid the brain produces. (nih.gov)
- Some children may have a procedure to place a shunt that will drain excess cerebrospinal fluid into the abdomen. (morganadamsfoundation.org)
Ventricle3
- 18. The slit-ventricle syndrome after shunting in hydrocephalic children. (nih.gov)
- They will place the tip of the shunt into a ventricle, a fluid-filled space in your brain. (webmd.com)
- The most common problem is a partial blockage of the flow of cerebrospinal fluid, either from one ventricle to another or from the ventricles to other spaces around the brain. (augustahealth.com)
Choroid plexus2
- Choroid plexus tumors are developed by brain tissue called "choroid plexus" by invading nearby tissue and spreading through the ventricles of the brain which are the interconnected cavities that contain cerebrospinal fluid. (morganadamsfoundation.org)
- Most choroid plexus tumors are noncancerous, though the cancerous form grows faster and is much more likely to spread through the cerebrospinal fluid and invade nearby tissue. (morganadamsfoundation.org)
Pediatric2
- Magnetic toys: forbidden for pediatric patients with certain programmable shunt valves? (sophysa.com)
- The number of shunts placed by pediatric neurosurgeons at Boston Children's has been reduced by around a third, meaning fewer revisions when a shunt fails. (nih.gov)
Drains2
- As the pressure of cerebrospinal fluid inside the brain or spine increases, the one-way valve opens and the excessive fluid drains to the downstream cavity. (medtronic.com)
- A higher pressure setting typically drains less CSF, and a lower pressure setting usually drains more fluid. (webmd.com)
Malfunction2
- Unfortunately, shunts have extremely high failure rates and diagnosing shunt malfunction is challenging due to a combination of vague symptoms and a lack of a convenient means to monitor flow. (bvsalud.org)
- Imaging guidelines are also outlined for initial evaluation and follow-up, along with a discussion of the imaging features of shunt malfunction. (nih.gov)
Programmable valves1
- Surgeons tend to choose programmable valves for most shunt placements. (webmd.com)
Complications2
- Infection (7.7%) and over- or under drainage (17.9%) were the most common complications requiring shunt revision in ten patients (25.6%), No peritoneal metastasis was found. (frontiersin.org)
- 14. Failure of cerebrospinal fluid shunts: part II: overdrainage, loculation, and abdominal complications. (nih.gov)
Surgical3
- Treatment typically involves the surgical implantation of a pressure -regulated silicone tube assembly, known as a shunt. (bvsalud.org)
- Several external adjustments of the valves apparently avoided several surgical shunt revisions. (sophysa.com)
- Placebo-Controlled Efficacy in iNPH Shunting (PENS) is a trial interested in assessing effectiveness of surgical cerebrospinal fluid shunting for iNPH treatment. (ucdavis.edu)
Blockage1
- As the tumor grows, it can increase pressure on the brain and cause a blockage of the cerebrospinal fluid. (morganadamsfoundation.org)
Diagnosis1
- Our specialists offer comprehensive diagnosis and treatment for children with Chiari malformation (brain tissue that extends into the spinal canal) and syringomyelia (a fluid-filled cyst in the spinal cord). (uclahealth.org)
Catheters2
- Shunts typically consist of two catheters and a valve that redirect excess fluid from the brain to another part of the body. (medtronic.com)
- A shunt usually consists of two catheters and a one-way valve. (medtronic.com)
Ventricles of the brain1
- Cerebrospinal fluid is produced by tissues lining the ventricles of the brain. (augustahealth.com)
Moves1
- The shunt moves the cerebrospinal fluid to another area of the body where it can be absorbed. (medlineplus.gov)
Systematic Review1
- Cerebrospinal Fluid Shunting for Idiopathic Intracranial Hypertension: A Systematic Review, Meta-Analysis, and Implications for a Modern Management Protocol. (harvard.edu)
Device1
- If you have a shunt, pacemaker, stent or any metallic implant, please forward operative notes from your surgeon with details of the make and type of the device. (hopkinsmedicine.org)
Involves2
- Treatment usually involves surgery to insert a shunt. (medlineplus.gov)
- Treatment involves inserting a shunt into the brain to route cerebrospinal fluid to another part of the body. (watsi.org)
Infection1
- Your surgeon will give you a list of symptoms of shunt infection and explain what to do if you have those symptoms. (webmd.com)
Treat1
- What Does a VP Shunt Treat? (webmd.com)
Spinal cord1
- Cerebrospinal fluid (CSF) collection is a test to look at the fluid that surrounds the brain and spinal cord. (nih.gov)
Abdomen1
- The surgeon will then make another incision in the abdomen and run the shunt under your skin down into your abdomen. (webmd.com)
Excess fluid1
- The excess fluid increases the size of the ventricles and puts pressure on the brain. (augustahealth.com)
Patients3
- Of note, 75% of the patients had a post-shunting oncological treatment such as radiotherapy or chemotherapy, most prevalently chemotherapy. (frontiersin.org)
- Between 1980 and 1983, 122 patients undergoing shunting procedures were randomly assigned to receive trimethoprim-sulfamethoxazole (Group 1, 62 cases) or a placebo (Group 2, 60 cases). (nih.gov)
- 8. Pregnancy in patients with cerebrospinal fluid shunts: report of a series and review of the literature. (nih.gov)
Lumbar1
- Lumbar puncture with fluid collection may also be part of other procedures such as an x-ray or CT scan after dye has been inserted into the CSF. (nih.gov)
Median1
- The median overall survival (OS) was 385 days and the median post shunting survival was 135 days. (frontiersin.org)
Outcome1
- 16. Maternal neurosurgical shunts and pregnancy outcome. (nih.gov)
Children2
- 9. Risk factors for recurrent shunt infections in children. (nih.gov)
- Their findings, published in the New England Journal of Medicine , showed that children in the shunt group had smaller ventricles a year post-operation than the ETV-CPC group, but brain growth and developmental outcomes for the two groups were the same. (nih.gov)
Tube1
- A shunt is a flexible but sturdy plastic tube. (medlineplus.gov)
Babies1
- Few series have addressed the problem of cerebrospinal fluid shunting in newborn babies. (sophysa.com)
Important1
- Please consult your healthcare professional for a full list of benefits, indications, precautions, clinical results, and other important medical information that pertains to shunts. (medtronic.com)
Flow1
- The valve regulates the amount, flow direction, and pressure of cerebrospinal fluid out of the brain's ventricles. (medtronic.com)
Problem1
- Less common is a problem with absorbing cerebrospinal fluid. (augustahealth.com)
Procedures1
- Results of trimethoprim-sulfamethoxazole prophylaxis in ventriculostomy and shunting procedures. (nih.gov)
Body1
- The extra fluid can build up because the body is either making too much of it or is not draining it properly. (webmd.com)
Place1
- The operation to place the shunt takes about an hour. (webmd.com)